featured
FOXP3+ Pro-Inflammatory T Cells: A Potential Therapeutic Target in Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The FOXP3+ Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn's Disease
Gastroenterology 2024 Apr 01;166(4)631-644.e17, RL Kosinsky, MM Gonzalez, D Saul, LL Barros, MR Sagstetter, Y Fedyshyn, A Nair, Z Sun, FH Hamdan, HR Gibbons, ME Perez Pachon, BR Druliner, SA Johnsen, WA FaubionFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.